ES2137900A1 - Use of formulations based on a water-soluble fraction of Phlebodium decumanum as a nutritional complement in the treatment of the cachectic syndrome in oncological patients. - Google Patents
Use of formulations based on a water-soluble fraction of Phlebodium decumanum as a nutritional complement in the treatment of the cachectic syndrome in oncological patients.Info
- Publication number
- ES2137900A1 ES2137900A1 ES009801139A ES9801139A ES2137900A1 ES 2137900 A1 ES2137900 A1 ES 2137900A1 ES 009801139 A ES009801139 A ES 009801139A ES 9801139 A ES9801139 A ES 9801139A ES 2137900 A1 ES2137900 A1 ES 2137900A1
- Authority
- ES
- Spain
- Prior art keywords
- treatment
- soluble fraction
- water
- formulations
- oncological patients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
Use of formulations based on a water-soluble fraction of Phlebodium decumanum as a nutritional complement in the treatment of the cachectic syndrome in oncological patients. The formulations include EXPLY-37, a purified and standardized water-soluble fraction of fronds of the variety of Phlebodium decumanum cultivated on the Lago Yojoa plantation (Honduras), together with, optionally, Phlebodium decumanum rhizome and the appropriate excipients for the presentation of these formulations in powder, capsule or syrup form. These formulations are suitable for the treatment by the oral route of the cachectic syndrome in oncological patients and as adjuvants in conventional oncological treatments (surgery and/or radiotherapy and chemotherapy) and in the recuperation of oncological patients after undergoing said treatments.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009801139A ES2137900B1 (en) | 1998-06-02 | 1998-06-02 | USE OF FORMULATIONS BASED ON A WATER-SOLUBLE FRACTION OF PHLEBODIUM DECUMANUM AS A NUTRITIONAL SUPPLEMENT IN THE TREATMENT OF KAQUECTIC SYNDROME IN ONCOLOGICAL PATIENTS. |
PCT/ES1998/000220 WO1999006058A1 (en) | 1997-07-30 | 1998-07-29 | Hydrosoluble fractions of phlebodium decumanum and use thereof as nutritional complements in aids and cancer patients |
EP98935039A EP1040834A1 (en) | 1997-07-30 | 1998-07-29 | HYDROSOLUBLE FRACTIONS OF $i(PHLEBODIUM DECUMANUM) AND USE THEREOF AS NUTRITIONAL COMPLEMENTS IN AIDS AND CANCER PATIENTS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009801139A ES2137900B1 (en) | 1998-06-02 | 1998-06-02 | USE OF FORMULATIONS BASED ON A WATER-SOLUBLE FRACTION OF PHLEBODIUM DECUMANUM AS A NUTRITIONAL SUPPLEMENT IN THE TREATMENT OF KAQUECTIC SYNDROME IN ONCOLOGICAL PATIENTS. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2137900A1 true ES2137900A1 (en) | 1999-12-16 |
ES2137900B1 ES2137900B1 (en) | 2000-08-16 |
Family
ID=8303982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES009801139A Expired - Fee Related ES2137900B1 (en) | 1997-07-30 | 1998-06-02 | USE OF FORMULATIONS BASED ON A WATER-SOLUBLE FRACTION OF PHLEBODIUM DECUMANUM AS A NUTRITIONAL SUPPLEMENT IN THE TREATMENT OF KAQUECTIC SYNDROME IN ONCOLOGICAL PATIENTS. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2137900B1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES471572A1 (en) * | 1978-07-07 | 1979-01-16 | Conrad Ltd | Anti-psoriatic fern extracts |
ES8104315A1 (en) * | 1980-04-02 | 1981-04-16 | Conrad Ltd | Arthritis treatment with fern extracts |
EP0503208A1 (en) * | 1991-03-08 | 1992-09-16 | Maracuyama International, S.A. | Procedure for obtaining a natural water-soluble extract from the leaves and/or rhizomes of various immunologically active ferns |
ES2068163B1 (en) * | 1994-05-06 | 1995-09-01 | Esp Farmaceuticas Centrum Sa | PROCEDURE FOR OBTAINING A PLANT EXTRACT WITH ACTIVITY IN THE TREATMENT OF COGNITIVE DYSFUNCTIONS AND / OR NEUROINMUNES. |
ES2088770A1 (en) * | 1995-02-23 | 1996-09-01 | Esp Farmaceuticas Centrum Sa | A pharmaceutical composition with activity in the treatment of cognitive and/or neuroimmune dysfunctions. |
WO1997023233A1 (en) * | 1995-12-21 | 1997-07-03 | Parbold Investments N.V. | Biologically active compositions and their use |
-
1998
- 1998-06-02 ES ES009801139A patent/ES2137900B1/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES471572A1 (en) * | 1978-07-07 | 1979-01-16 | Conrad Ltd | Anti-psoriatic fern extracts |
ES8104315A1 (en) * | 1980-04-02 | 1981-04-16 | Conrad Ltd | Arthritis treatment with fern extracts |
EP0503208A1 (en) * | 1991-03-08 | 1992-09-16 | Maracuyama International, S.A. | Procedure for obtaining a natural water-soluble extract from the leaves and/or rhizomes of various immunologically active ferns |
ES2068163B1 (en) * | 1994-05-06 | 1995-09-01 | Esp Farmaceuticas Centrum Sa | PROCEDURE FOR OBTAINING A PLANT EXTRACT WITH ACTIVITY IN THE TREATMENT OF COGNITIVE DYSFUNCTIONS AND / OR NEUROINMUNES. |
ES2088770A1 (en) * | 1995-02-23 | 1996-09-01 | Esp Farmaceuticas Centrum Sa | A pharmaceutical composition with activity in the treatment of cognitive and/or neuroimmune dysfunctions. |
WO1997023233A1 (en) * | 1995-12-21 | 1997-07-03 | Parbold Investments N.V. | Biologically active compositions and their use |
Non-Patent Citations (1)
Title |
---|
HORVATH, A. et al. Metabolic effects of Calagualine, an antitumoral saponine of Polypodium leucotomos. NATURE, Londres, Junio 1967. Vol. no 214, paginas 1256-1258. * |
Also Published As
Publication number | Publication date |
---|---|
ES2137900B1 (en) | 2000-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP083351A (en) | PHARMACEUTICAL COMPOSITIONS | |
TR200002299T2 (en) | Epothilon compositions. | |
AP9801392A0 (en) | Concentrated antibody preparation. | |
NO20012774D0 (en) | Preparation and method using essential plant oils | |
WO2004112711A3 (en) | Oral extended-release composition | |
CY1105170T1 (en) | ORAL PRESCRIPTION OF LIGHTNING - MELTING DOSAGE | |
HUP0001382A2 (en) | Extended release formulations of erythromycin derivatives | |
HK1060694A1 (en) | Herbal compositions useful as chemopreventive and therapeutic agents. | |
DK0703786T3 (en) | Use of nona- and decapeptides for the manufacture of a medicament for the treatment of AIDS | |
AU6788687A (en) | A pharmaceutical which can be administered nasally, a process for its preparation, and its use | |
ES2137900A1 (en) | Use of formulations based on a water-soluble fraction of Phlebodium decumanum as a nutritional complement in the treatment of the cachectic syndrome in oncological patients. | |
NO20033699L (en) | Stable pharmaceutical formulation comprising torsemide modification II | |
HK1075654A1 (en) | Hyperforin derivatives, the use thereof and formulations containing them | |
EP1273301A3 (en) | Pharmaceutical preparations based on active ingredients susceptible to illict administration | |
WO2001034174A3 (en) | Methods for administration of therapeutic agents on an antiangiogenic schedule | |
DE58904108D1 (en) | DRUG. | |
ES2124675A1 (en) | Formulations based on a water-soluble fraction of Phlebodium decumanum, and use thereof in the treatment of the cachectic syndrome in AIDS patients | |
AU3478600A (en) | Treatment of autoimmune diseases with american ginseng extract | |
MD2068F1 (en) | Method of treatment of the Herpes simplex infection | |
UA28031C2 (en) | Medicinal form of derivatives 5-nitroimidasole, pharmaceutical composition for gastrointestinal tract parasitic and infectious deseases treatment. gastroprotected microgranules of derivatives 5-nitroimidasole, microgranules of derivatives 5-nitroimidasole with a prolonged release of a medicinal agent. | |
RU2001134578A (en) | A method for the treatment of chronic intestinal diseases associated with dysbiosis | |
UA29645A (en) | Natural drug (variants) | |
GEP20002177B (en) | Ointment “Levaskani” for Treatment of Wounds and Burns | |
UA36542A (en) | Denture | |
DE50211461D1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING BULBOPHYLLUM |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 19991216 Kind code of ref document: A1 Effective date: 19991216 |
|
FD1A | Patent lapsed |
Effective date: 20070604 |